Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P000054/S075

INFUSE BONE GRAFT

MEDTRONIC SOFAMOR DANEK USA, INC. · Decision date Aug 26, 2026

FDA DECISIONP000054/S075

What did the FDA approve?

FDA records P000054/S075 as a supplement to PMA P000054, with the supplement type “Normal 180 Day Track”. The recorded decision is approval, dated Aug 26, 2026.

FDA approval order statement

Approval for a change to the potency testing of rhBMP-2 used in the manufacturing of INFUSE Bone Graft.
Regulatory pathway
PMA supplement
Supplement type
Normal 180 Day Track
Clinical specialty
Orthopedic
Decision date
Aug 26, 2026
FDA change category
Change Design/Components/Specifications/Material

FDA source record

Regulatory record facts

Identifier
P000054/S075
Regulatory pathway
PMA supplement
Product code
MPW
Decision code
APPR
Decision date
Aug 26, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Filler, recombinant human bone morphogenetic protein, collagen scaffold, osteoinduction.

Product code
MPW
FDA device class
3

Review the original FDA PMA listing for the original approval scope and linked supplements.

FDA decision timeline

  1. P000054/S075 received

    Application receipt date recorded by FDA.

  2. P000054/S075 · FDA decision

    Normal 180 Day Track

Timeline entries are records held by MedtechLedger for P000054. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P000054

Product / regulatory recordCompanyPathwayDecision dateSource
INFUSE Bone GraftP000054/S076
MEDTRONIC SOFAMOR DANEK USA, INC.PMA supplementFeb 24, 2026FDA
INFUSE Bone GraftP000054/S077
MEDTRONIC SOFAMOR DANEK USA, INC.PMA supplementMar 19, 2026FDA
Infuse Bone GraftP000054/S078
MEDTRONIC SOFAMOR DANEK USA, INC.PMA supplementJul 28, 2026FDA

Explore the linked device profile

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Medtronic Sofamor DANEK USA, Inc.

Headquarters
Not reported
Brand website
medtronic.com
FDA applicant address
1800 Pyramid Pl., Memphis, TN, 38132

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records